MedPath

A Study To Evaluate the Feasibility of the Decentralized Clinical Trial in South Korea

Not Applicable
Completed
Conditions
Functional Dyspepsia
Interventions
Behavioral: Dietary modification
Dietary Supplement: Mastic gum
Registration Number
NCT06005805
Lead Sponsor
Seoul National University Hospital
Brief Summary

The goal of this study is to evaluate the feasibility of a decentralized clinical trial in South Korea. The main questions it aims to answer are:

* Does decentralized elements feasible in Korea?

* Does Mastic gum alleviates symptoms and modifies stool microbiome in Korean patients with functional dyspepsia?

Detailed Description

The trial aims to evaluate decentralized elements in South Korea, including clinical laboratory testing using local laboratories, medication adherence assessment using wearable devices, analysis of self-kit specimens, delivery and tracking of investigational medication, real-time remote interview of subjects and e-consent acquisition.

Mastic gum is registered with the Ministry of Food and Drug Safety in South Korea as a dietary supplement for gastric health, and the study aims to explore the effect on the gastrointestinal symptoms and composition of the stool microbiome.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dietary modificationDietary modificationDietary modification (for 21 days)
Mastic gum with dietary modificationDietary modificationMastic gum with dietary modification (for 21 days)
Mastic gum with dietary modificationMastic gumMastic gum with dietary modification (for 21 days)
Primary Outcome Measures
NameTimeMethod
Self-kit success rateup to 1 months

Fraction of patients who utilized and delivered a self-test kit on the scheduled date

Adverse event management timeup to 1 months

In the event of an adverse event requiring medical attention, time from report to response

Specimen delivery timeup to 1 months

Time from collection at the local laboratory to delivery of specimen and reporting of results

Secondary Outcome Measures
NameTimeMethod
Self-evaluation questionnaire for dyspepsia (SEQ-DYSPEPSIA) scorebaseline, immediately after the intervention

A self-evaluation questionnaire for dyspepsia score comprised 11 symptoms. Each symptom is measured on a 5-point scale for both frequency and intensity. The total score range from 22 to 110 and higher scores mean a worse outcome.

Gut Microbiome Indexbaseline, immediately after the intervention

An index that combines microbial diversity, the proportion of pro-inflammatory microbes, the proportion of microbes that produce anti-inflammatory substances, and similarity to hunter-gatherers.

Trial Locations

Locations (1)

Seoul National University Hospital Clinical Trial Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath